arrow
S

Silvia La Monica

Department of Medicine and Surgery
H指数:35
被引数:2,887

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The anti-tumor efficacy of CDK4/6 Inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells (vol 37, 72, 2018)

CDK4/6抑制剂的抗肿瘤效果通过与PI3K/AKT/mTOR抑制剂的联合应用而增强,其机制是通过抑制TNBC细胞的葡萄糖代谢(卷37,期72,2018)。

2025-04-160
OA
Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines

靶向葡萄糖饥饿诱导的代谢适应性反应抑制奥希替尼耐药非小细胞肺癌 (NSCLC) 细胞系的细胞增殖并增加细胞死亡

2024-10-011
OAAI
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models

靶向葡萄糖神经酰胺合酶在奥希替尼耐药的NSCLC细胞模型中诱导抗增殖和促凋亡作用

2024-03-181
OAAI
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC Brief Report of Clinical and Preclinical Proofs
2022-02-014
OA
A sulfonyl fluoride derivative inhibits EGFRL858R/T790M/C797S by covalent modification of the catalytic lysine

磺酰氟衍生物通过催化赖氨酸的共价修饰抑制EGFRL858R/T790M/C797S

2021-12-0132
PREAI
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells

间充质基质细胞对人恶性胸膜间皮瘤生长的抑制作用

CELLS
IF5.2
2021-06-0811
OAAI